[Smoking and induction of the enzyme aryl hydrocarbon hydroxylase in patients with laryngeal carcinomas and precancerous conditions].
The risk for a smoker of developing cancer of the larynx depends on the activity of the enzyme arylhydroxcarbonhydroxylase in his cells. The higher the genetically determined arylhydroxcarbonhydroxylase activity, the higher is the probability of developing the disease.
D001189:Aryl Hydrocarbon Hydroxylases / Q000097:blood*; D002908:Chronic Disease; D004790:Enzyme Induction; D005260:Female; D006801:Humans; D007819:Laryngeal Edema / Q000201:enzymology; D007822:Laryngeal Neoplasms / Q000201:enzymology*; D007827:Laryngitis / Q000201:enzymology; D007971:Leukoplakia / Q000201:enzymology; D008214:Lymphocytes / Q000201:enzymology; D008297:Male; D011230:Precancerous Conditions; D012907:Smoking; D013050:Spectrometry, Fluorescence
D001189:Aryl Hydrocarbon Hydroxylases
Rauchen und Induktion des Enzyms Arylhydroxkarbonhydroxylase bei Patienten mit Karzinomen und Präkanzerosen des Larynx.